Higher mortality during heatwave in July in the Netherlands During the last heatwave, almost 400 more deaths were reported than was expected on overage for that period. The additional deaths mainly concerned persons aged 75 years and older.
Longest ever recorded flu epidemic measured in 2015 The most notable infectious disease outbreak in 2015 was the flu epidemic in the winter of 2014-2015, which at 21 weeks was the longest ever recorded in the Netherlands.
First patient infected by tick-borne encephalitis virus For the first time, a person in the Netherlands has fallen ill after a bite from a tick carrying the tick-borne encephalitis virus (TBE virus).
Livestock farming affects pulmonary function in local residents COPD patients living near livestock farms suffer more complications.
Nicoline Tamsma re-elected as EuroHealthNet president Nicoline Tamsma has been elected to serve a new two-year term as EuroHealthNet president. EuroHealthNet is a European network organisation of public health and health promotion institutes.
Bacteria slightly more often resistant to last resort antibiotics Antimicrobial resistance is a global problem. In the Netherlands, some bacteria that can cause infections in people are more frequently resistant to antibiotics used as a last resort.
RIVM and German BfR enter cooperation agreement on animal protection and food safety The German Federal Institute of Risk Assessment (BfR) and the Dutch National Institute for Public Health and the Environment, RIVM have signed a cooperation agreement, focused on developing new sci
Mental care still the most expensive of all In 2011, 19.6 billion euros was spent on the treatment of mental disorders. This amounted to 22% of the total expenditure on health and welfare during that year.
Risks of eHealth technology RIVM and Nictiz have made an overview of the risks that eHealth applications may entail and how these risks can be controlled.
Key organisations unite to improve benefit and risk assessments of vaccines Leading organisations have joined forces to launch a unique project that will pave the way for a pan-European framework for rapidly assessing and communicating the benefits and risks of vaccines.